Want to see OSCR full AI Analyst Report?
OSCR Stock Chart & Stats
$15.79
$0.74(5.14%)
At close: 4:00 PM EST
$15.79
$0.74(5.14%)
Day’s Range― - ―
52-Week Range$10.69 - $33.10
Previous CloseN/A
Volume1.52M
Average Volume (3M)6.87M
Market Cap
$9.21B
Enterprise Value$2.96B
Total Cash (Recent Filing)$6.80B
Total Debt (Recent Filing)$430.88M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Aug 06, 2026EPS Estimate
0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding265,902,000
10 Day Avg. Volume5,024,441
30 Day Avg. Volume6,870,031
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.86
Price to Sales (P/S)0.32
P/FCF Ratio3.56
Enterprise Value/Market Cap0.32
Enterprise Value/Revenue0.22
Enterprise Value/Gross Profit1.28
Enterprise Value/Ebitda153.68
Forecast
1Y Price Target
$20.71Price Target Upside31.19% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.04
Revenue Forecast (FY)$18.53B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSustained multi‑billion dollar operating and free cash flow provides durable financial flexibility: it funds working capital, supports insurance subsidiary capital needs, reduces reliance on external financing, and enables continued investment in technology and distribution. Consistent FCF underpins solvency and strategic optionality even if earnings remain volatile.
Rapid Membership And Revenue ScaleLarge, accelerating member growth and strong top‑line expansion create durable scale advantages: broader risk pools, improved negotiating leverage with providers, fixed‑cost absorption and distribution leverage. Scale supports long‑term premium revenue stability and provides structural runway to deepen product offerings and improve margins over time.
Improved Balance Sheet And Capital AdequacyMarked improvement in leverage and expanded equity plus large cash holdings strengthen solvency and regulatory capital buffers for the insurance business. A healthier balance sheet increases resilience to adverse claims/morbidity shocks, supports underwriting capacity, and permits continued product and distribution investment without immediate capital raises.
Bears Say
Thin, Inconsistent ProfitabilityNear‑breakeven margins and swings between profit and loss reduce confidence in durable earnings power. Thin margins leave limited room to absorb underwriting volatility, reserve shocks, or adverse claims trends; they also constrain reinvestment and shareholder returns unless sustained margin improvement continues across multiple quarters.
Risk-adjustment Timing And VolatilityMaterial swings in risk‑adjustment transfers create persistent timing and earnings volatility because payments depend on relative enrollee morbidity and external reporting. Elevated or unpredictable RA can distort revenue and underwriting results across quarters, complicating pricing, capital planning and the ability to demonstrate consistent underwriting performance.
Reserve Development And State-level VariabilityMaterial reserve runout variability across states signals persistent actuarial and operational risk. Uneven reserve developments can unpredictably affect reported earnings and capital, necessitating conservative reserving or higher capital buffers. This variability undermines forecasting precision and can pressure margins over multiple reporting periods.
Oscar Health News
OSCR FAQ
What was Oscar Health, Inc.’s price range in the past 12 months?
Oscar Health, Inc. lowest stock price was $10.69 and its highest was $33.10 in the past 12 months.
What is Oscar Health, Inc.’s market cap?
Oscar Health, Inc.’s market cap is $9.21B.
When is Oscar Health, Inc.’s upcoming earnings report date?
Oscar Health, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 24 days.
How were Oscar Health, Inc.’s earnings last quarter?
Oscar Health, Inc. released its earnings results on May 06, 2026. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.108 by $0.962.
Is Oscar Health, Inc. overvalued?
According to Wall Street analysts Oscar Health, Inc.’s price is currently Undervalued.
Does Oscar Health, Inc. pay dividends?
Oscar Health, Inc. does not currently pay dividends.
What is Oscar Health, Inc.’s EPS estimate?
Oscar Health, Inc.’s EPS estimate is 0.37.
How many shares outstanding does Oscar Health, Inc. have?
Oscar Health, Inc. has 265,902,000 shares outstanding.
What happened to Oscar Health, Inc.’s price movement after its last earnings report?
Oscar Health, Inc. reported an EPS of $2.07 in its last earnings report, beating expectations of $1.108. Following the earnings report the stock price went up 10.591%.
Which hedge fund is a major shareholder of Oscar Health, Inc.?
Currently, no hedge funds are holding shares in OSCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oscar Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$20.71 (31.19% Upside)
$20.71 (31.19% Upside)
Blogger Sentiment
Bullish
OSCR Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 676.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $11.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
96.65%
12-Months-Change
Fundamentals
Return on Equity
-3.27%
Trailing 12-Months
Asset Growth
61.72%
Trailing 12-Months
Company Description
Oscar Health, Inc.
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
OSCR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated robust top-line growth, record membership, strong profitability and a healthy balance sheet, with management highlighting AI/product initiatives and new distribution channels (Lucie, ICHRA X). Primary near-term concerns center on elevated early-year risk adjustment, seasonally low claims that affect RA and revenue timing, some prior-period reserve variability, and expected churn normalization. Management expressed confidence—reaffirming full-year guidance—and emphasized improving visibility after Q2 claims and Wakely reports.View all OSCR earnings summariesOSCR Stock 12 Month Forecast
Average Price Target
$20.71
▲(31.19% Upside)
Technical Analysis
Centene
―
Humana
―
Molina Healthcare
―
Clover Health Investments
―
Alignment Healthcare
―
Ownership Overview
4.53% Insiders
16.63% Mutual Funds
0.96% Other Institutional Investors
59.44% Public Companies and Individual Investors